Harel Insurance Investments & Financial Services’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $856K | Sell |
12,397
-549,790
| -98% | -$38M | 0.01% | 183 |
|
|
2025
Q1 | $39.5M | Buy |
+562,187
| New | +$39.5M | 0.52% | 48 |
|
|
2024
Q4 | – | Sell |
-2,759
| Closed | -$329K | – | 503 |
|
|
2024
Q3 | $329K | Sell |
2,759
-1,100
| -29% | -$131K | 0.01% | 196 |
|
|
2024
Q2 | $554K | Sell |
3,859
-233
| -6% | -$33.5K | 0.01% | 174 |
|
|
2024
Q1 | $525K | Sell |
4,092
-553,562
| -99% | -$71M | 0.01% | 165 |
|
|
2023
Q4 | $57.7M | Buy |
557,654
+550
| +0.1% | +$56.9K | 1.01% | 31 |
|
|
2023
Q3 | $50.7M | Buy |
557,104
+554,200
| +19,084% | +$50.4M | 1% | 30 |
|
|
2023
Q2 | $232K | Sell |
2,904
-8,706
| -75% | -$696K | 0.01% | 299 |
|
|
2023
Q1 | $919K | Sell |
11,610
-4,770
| -29% | -$378K | 0.02% | 177 |
|
|
2022
Q4 | $1.11M | Buy |
16,380
+4,428
| +37% | +$299K | 0.02% | 154 |
|
|
2022
Q3 | $599K | Buy |
11,952
+10,382
| +661% | +$520K | 0.01% | 196 |
|
|
2022
Q2 | $87K | Sell |
1,570
-1,670
| -52% | -$92.5K | ﹤0.01% | 426 |
|
|
2022
Q1 | $180K | Sell |
3,240
-20,430
| -86% | -$1.14M | ﹤0.01% | 359 |
|
|
2021
Q4 | $1.32M | Buy |
23,670
+7,822
| +49% | +$435K | 0.02% | 156 |
|
|
2021
Q3 | $761K | Buy |
15,848
+3,448
| +28% | +$166K | 0.02% | 179 |
|
|
2021
Q2 | $1.69M | Buy |
+12,400
| New | +$1.69M | 0.04% | 221 |
|
|
2019
Q1 | – | Sell |
-120
| Closed | -$3K | – | 489 |
|
|
2018
Q4 | $3K | Buy |
+120
| New | +$3K | ﹤0.01% | 442 |
|
|
2016
Q3 | – | Sell |
-480
| Closed | -$13K | – | 611 |
|
|
2016
Q2 | $13K | Buy |
+480
| New | +$13K | ﹤0.01% | 533 |
|